How do we help cervical cancer patients?
We review your case and provide a list of options from available cervical cancer clinical trials close to your home as part of Massive Bio SYNERGY-AI program or Massive Bio Virtual Tumor Board solution.
There are approximately 400 clinical trials across the US for cervical cancer. Would any of them be beneficial to you for cervical cancer treatment?
Cervical Cancer Facts
There are over 500,000 new cases of cervical cancer diagnosed each year worldwide. 70% of patients’ tumors will have genomic alterations. Do you know all of your options?
Massive Bio support you through your cancer journey. You can have direct conversation with our advocates, and oncology nurses, and receive artificial intelligence support analysis from our network of doctors.
HPV is the biggest risk factor directly leading to cervical cancer. Other risk factors include smoking, giving birth to multiple children, and using the oral form of contraceptives over a long period of time. Symptoms usually don’t occur until the cancer has spread to other organs, so it is difficult to diagnose in the cancer’s early stages.
There are several forms of treatment that are common among cervical cancer patients. The form of treatment used typically depends on the stage of the cancer. These treatment options are chemotherapy, radiation therapy, immunotherapy, and surgery. While there are multiple types of surgeries that can be performed, they usually consist of removing part of or all the cervix for later stages, or attempting to remove only the cancerous cells by devices like electric currents or a scalpel.
The pap smear test is the most common form of screening for cervical cancer. This test involves gently scraping cells from the cervix to be tested for any abnormalities.
Another common way to detect cervical cancer is a standard blood test. Oncologists use a plasma thermogram to indicate any presence of cervical cancer and the stage of the cancer.
Learn Your Cervical Cancer Clinical Trial and Treatment Options
The five-year survival rate for cervical cancer patients is Nearly 66% which is slightly lower than the average five-year survival rate for all cancers (70%)
Thanks to an increase in awareness of the pap smear tests and the risk factors associated with cervical cancer, new cases have decreased from 14.8 per 100,000 women in 1975 to 6.4 per 100,000 women in 2016. Deaths have also decreased from 5.5 women per 100,000 to 2.2 per 100,000 women. Cervical cancer used to be known as one of the more deadly cancer types. Now, the survival rate is nearly even with the average survival rate for all cancer types.
- Squamous cell carcinoma
Cervical Cancer Clinical Trial:
Phase 1 / 2 Study of AGEN2034 in Advanced Tumors and Cervical Cancer